Skip to main content

Study of 20,000 COVID-19 patients shows treatment with survivor plasma is safe

Noted: The study shows a decent representation of minorities,” said William Hartman, an assistant professor of anesthesiology at UW Health. “That’s an important point given that the minority communities have been hit so, so hard by COVID-19.”

Hartman is leading survivor plasma trials at the University of Wisconsin-Madison. He was not involved with this study.

Author Jordan Nutting is a AAAS Mass Media Fellow writing about science at the Milwaukee Journal Sentinel this summer. She’s working on a Ph.D. in organic chemistry at the University of Wisconsin-Madison.